Picking the best Solid Phase DNA Synthesis company in China? It’s not just about who gives you the lowest price. You really need to look at the chemistry behind it, their quality systems, how much they can produce, and what customers actually say. Grand View Research expects the global synthetic biology market to grow fast through 2030. MarketsandMarkets also sees strong growth in DNA synthesis, pushed by biotech, diagnostics, and pharma research. Those numbers show there’s demand, sure—but they don’t guarantee every supplier out there will hand you reliable oligos.
Marvin H. Caruthers, one of the pioneers of phosphoramidite chemistry, once said, “The phosphoramidite method has become the method of choice for DNA synthesis.” His work still underpins a lot of modern solid-phase production. In practice, a supplier you can trust should show high coupling efficiency, clean deprotection, consistent purification, and quality control you can trace. GenScript, Sangon Biotech, and BGI are some of the China-based names international research teams often mention. But their strengths vary—synthesis scale, modified bases, turnaround time, documentation, that sort of thing.
No ranking is ever perfect. And that’s kind of the point. A small lab might care most about flexible ordering and quick technical support, while a pharma customer may want validated processes, batch records, and regulatory readiness. Reports also define “the market” differently, so their forecasts deserve a careful read. This article will compare leading Chinese providers using measurable criteria: analytical data, synthesis accuracy, turnaround performance, and how transparent their service is. The best company might not be the cheapest. It might be the one that gives you a clean, fully documented sequence when your experiment absolutely cannot afford a do-over.
Solid-phase DNA synthesis builds a DNA strand one nucleotide at a time. The first nucleotide attaches to a tiny solid support, often controlled-pore glass. The instrument then repeats several chemical steps. These include deprotection, coupling, capping, and oxidation. Each cycle adds one base to the growing sequence.
This process offers precise control over short DNA oligonucleotides. It supports primers, probes, gene fragments, and other research materials. After synthesis, the strand is removed from the support and purified. Common methods include cartridge purification, HPLC, and PAGE. Mass spectrometry can then check molecular weight and confirm identity. Small details matter. Moisture, reagent quality, and cycle efficiency can affect the final sequence.
Choosing a reliable company in China requires more than comparing prices. A capable provider should explain synthesis scales, purification options, expected yields, and quality-control methods. Clear technical communication is equally important, especially for modified bases or longer sequences. Detailed records, traceable production, and stable delivery schedules show professional practice. No synthesis is perfect. Longer sequences usually carry greater error risks, even when the process is carefully controlled. I would therefore review sample reports, analytical data, and customer support before making a decision. A low quotation may look attractive, but weak purification can create extra work in the laboratory.
When evaluating a solid-phase DNA synthesis company in China, look beyond catalog prices and attractive webpages. A reliable supplier should explain its synthesis scale, coupling efficiency, purification options, and typical turnaround time. Ask for recent, anonymized quality documents, including analytical HPLC, mass spectrometry, concentration, and sequence verification data. Ask for evidence.
Experience often appears in small operational details. Can the technical team discuss difficult GC-rich sequences, long oligonucleotides, fluorescent modifications, and repeated synthesis failures? Do they provide clear sample labeling and traceable batch records? Details matter. A pilot order can reveal whether the reported quality matches the delivered material. However, one successful batch does not prove stable performance across months.
Evaluate the company’s quality system, facility controls, staff expertise, and communication process. Confirm whether relevant certificates are current and applicable to the requested service, rather than accepting logos without verification. Review packaging, temperature protection, shipping documentation, and support for import requirements. A dependable supplier should state its acceptance criteria and explain how it handles deviations or failed synthesis. Response speed is useful, but technical accuracy matters more. My own evaluation would not rely on price alone; low cost may hide limited purification or inconsistent documentation. Still, even a detailed checklist has weaknesses, because supplier performance can change after scaling up. Regular requalification is sensible.
Leading Chinese providers now offer more than basic oligonucleotide production. Their services commonly include custom primers, probes, modified oligos, and small-scale screening libraries. Many also provide desalting, cartridge purification, HPLC, and PAGE purification. These options support different research needs, from routine PCR to demanding diagnostic development.
Quality evidence matters. The 2024 MarketsandMarkets report estimates the global oligonucleotide synthesis market at about USD 8.3 billion in 2023. It also forecasts strong growth through 2028, driven by therapeutics, diagnostics, and molecular research. This expansion increases demand for reliable solid-phase DNA synthesis and faster delivery. However, market growth does not guarantee consistent service.
A capable Chinese provider should offer mass spectrometry, purity data, yield records, and batch traceability. Clear technical support is equally valuable. Procurement teams should compare coupling efficiency, purification recovery, modification capability, and realistic turnaround times.
Certificates should match the actual batch, not a generic template. Secure data handling and documented quality systems also deserve attention. ISO 9001 certification can support process control, but it does not replace product-specific testing.
No supplier is perfect. A failed long sequence may reveal weaknesses hidden by short, simple orders. That is why pilot batches and independent sequence verification remain sensible.
The best supplier should prove quality through records, not polished claims. Solid-phase synthesis depends on repeated coupling, washing, and deprotection cycles. Even a 99% coupling efficiency can create noticeable truncated sequences after many cycles. A 2024 industry market report estimated continued double-digit growth in oligonucleotide manufacturing, increasing pressure on analytical capacity and batch consistency. Buyers should request coupling-efficiency data, failure-rate trends, and representative certificates of analysis.
Manufacturing capability must extend beyond the synthesizer. Look for controlled production rooms, validated equipment, electronic batch records, and raw-material traceability. HPLC and LC-MS testing should confirm purity, identity, and molecular mass. For regulated projects, documented GMP procedures and audit-ready deviation handling are essential. International quality guidance also emphasizes risk-based controls, change management, and supplier qualification. These details matter more than production volume alone.
Experience can reveal practical weaknesses. Some facilities report impressive throughput but provide limited stability data or unclear acceptance criteria. That deserves scrutiny. A reliable Chinese manufacturer should support small feasibility batches, scale-up studies, and reproducible delivery schedules. ISO-certified systems are useful, but certification alone does not guarantee sequence quality. Ask for recent trend charts, method-validation summaries, and evidence of corrective actions. The strongest choice combines measurable quality standards with transparent manufacturing discipline.
Choosing the best solid phase DNA synthesis company in China requires more than comparing a price list. Cost depends on sequence length, purification, modification, and delivery conditions. A low quotation may exclude analytical testing or difficult-sequence fees. Request an itemized quotation before judging value. It should show synthesis yield, purification options, quality data, and shipping terms.
Speed matters when experiments follow tight schedules. Standard oligonucleotides may move quickly, while long, GC-rich, or heavily modified sequences usually require more time. Ask for separate timelines for design review, synthesis, quality control, and dispatch. A capable supplier should explain delays clearly. Silence is a warning sign.
Scale also deserves close attention. Small research orders and high-volume production need different equipment, workflows, and quality controls. Check whether the facility can maintain consistent purity across repeated batches. Technical support is equally important. Experienced specialists can review secondary structures, unusual modifications, and purification choices before production. That advice can prevent an expensive failed batch. Look for documented quality procedures, traceable records, and responsive communication from trained staff. Certifications help, but they do not replace practical answers. No scoring model is perfect. I would test a supplier with several representative sequences before signing a larger agreement, because real performance may differ from a polished capability sheet.
| Anonymous Provider Profile | Typical Service Positioning | Indicative Cost for Standard Desalted DNA Oligo* | Typical Turnaround Time | Routine Synthesis Scale | Maximum Common Length | Modification Capability | Technical Support Score | Best-Fit Use Case |
|---|---|---|---|---|---|---|---|---|
| Profile A | High-throughput domestic oligonucleotide manufacturer | US$0.03–0.10 per base | 2–4 working days | Tube, 96-well, and 384-well formats | Up to approximately 150 bases for routine projects | Common fluorophores, biotin, phosphorothioate, and purification options | 4.5/5 | Large screening libraries and recurring research orders |
| Profile B | Research-focused DNA synthesis specialist | US$0.04–0.14 per base | 3–6 working days | Tube and 96-well formats; moderate batch capacity | Approximately 150–200 bases, project dependent | Standard labels, controlled-pore glass purification, HPLC, and PAGE | 4.3/5 | Academic laboratories and custom short-to-medium oligos |
| Profile C | Integrated gene and oligonucleotide service provider | US$0.06–0.18 per base | 4–8 working days | Tube, plate, and project-based batch production | Approximately 180–250 bases with sequence review | Broad modification menu, analytical QC, and purification upgrades | 4.6/5 | Projects combining primers, probes, genes, and downstream cloning |
| Profile D | Cost-optimized bulk synthesis supplier | US$0.02–0.08 per base at volume | 4–10 working days | 96-well and 384-well bulk production | Approximately 100–150 bases for routine orders | Core modifications available; complex modifications may require review | 3.8/5 | Price-sensitive, high-volume primer and screening programs |
| Profile E | Complex-modification and analytical-support provider | US$0.10–0.35 per base, excluding special modifications | 7–15 working days | Small to medium batches with project scheduling | Approximately 120–200 bases, depending on chemistry | Special fluorophores, linkers, dual labels, purification, and analytical confirmation | 4.7/5 | Diagnostic research, assay development, and difficult sequences |
*Prices are indicative China-market benchmark ranges for unmodified, standard-scale DNA oligonucleotides and may exclude setup fees, purification, labeling, tax, shipping, and special sequence surcharges. Actual quotations vary according to synthesis scale, base composition, length, purification method, modification chemistry, quality-control requirements, and order volume. Turnaround times are typical production estimates after sequence confirmation.
Choosing the best solid phase DNA synthesis company in China requires more than comparing prices. MarketsandMarkets estimated the global DNA synthesis market at about USD 3.2 billion in 2023, with continued growth driven by biotechnology and drug research. This expansion increases supplier choices, but quality differences remain important. Ask for coupling-efficiency data, typical failure rates, purification options, and independent quality records. A low price can still become expensive when one failed sequence delays an experiment.
Match the supplier to your research workflow. Short oligonucleotides may only need standard desalting, while long or GC-rich sequences often require stronger purification and sequence verification. Request HPLC or mass spectrometry results for representative orders. Confirm whether the company provides batch traceability, secure sequence handling, and documented corrective actions. ISO 9001 certification can indicate controlled processes, but it does not prove every sequence is perfect. Look deeper.
The 2024 BCC Research analysis identified synthetic biology and molecular diagnostics as major demand areas for DNA synthesis services. That trend suggests growing pressure on turnaround time and technical support. Ask about realistic delivery windows, not advertising promises. Evaluate how specialists handle failed synthesis, redesign advice, and urgent revisions. The best choice may not be the fastest. It should be consistent, transparent, and responsive to your actual protocol. I would also request a small pilot order before committing to long-term purchasing. That step feels cautious, perhaps overly cautious, but one successful test cannot represent every difficult sequence.
HY 12 is designed for medium-scale DNA and RNA oligo synthesis, supporting laboratories that need dependable throughput without the complexity of large industrial platforms. Recent market analyses of the oligonucleotide sector emphasize growing demand from molecular diagnostics, genetic research, sequencing workflows, and personalized testing. In this environment, a flexible synthesis system can help laboratories respond efficiently to varied project requirements while maintaining consistent production quality.
Synthesized primers produced with HY 12 can be applied to sequencing reactions, SNP locus analysis, detection kits, hybridization experiments, reverse transcription, and polymerase chain reaction (PCR). The platform can also support the synthesis of other primer types through different programming options, allowing users to adapt workflows according to sequence design, scale, and application. Its medium-scale positioning is suitable for research institutions, diagnostic development teams, and laboratories managing multiple oligo projects. By combining programmable operation with practical production capacity, the system can support routine primer preparation as well as specialized molecular biology workflows.
Ask about synthesis scale, coupling efficiency, purification methods, and typical delivery times. Request recent, anonymized quality records before ordering.
Request analytical HPLC, mass spectrometry, concentration, and sequence verification data. These documents show actual batch quality, not just website claims.
Ask how specialists handle GC-rich sequences, long oligonucleotides, and fluorescent modifications. Their answers should include practical failure examples.
A small pilot order tests labeling, purity, packaging, communication, and delivery. One successful batch proves little.
Standard desalting may suit short oligonucleotides. Longer or GC-rich sequences may need stronger purification and sequence verification.
It is very important. Each sample should have clear labeling, batch records, concentration data, and documented corrective actions.
Not necessarily. A low price may hide limited purification or incomplete documentation. A failed sequence can delay an experiment and increase costs.
Confirm temperature protection, shipping documents, import support, and realistic delivery windows. Fast replies help, but accurate technical answers matter more.
No. Certification can indicate controlled processes, but it cannot guarantee every sequence is perfect. Verify recent records and inspect delivered samples.
Review performance regularly, especially after production scaling. Suppliers can change over time, so requalification remains sensible, even if it feels excessive.
Solid Phase DNA Synthesis is a reliable method for producing custom DNA fragments by adding nucleotides step by step to a solid support. When evaluating a DNA synthesis company in China, researchers should consider its technical expertise, sequence design assistance, synthesis accuracy, purification options, quality-control procedures, and ability to handle different project sizes. Strong providers typically offer services such as gene fragments, oligonucleotides, modified sequences, cloning support, and analytical documentation.
The best company should demonstrate consistent manufacturing capabilities, clear quality standards, dependable delivery schedules, and responsive technical support. Cost is important, but it should be assessed alongside turnaround time, synthesis scale, error rates, purification requirements, and project complexity. Researchers can make a suitable choice by comparing quotations, reviewing quality documentation, confirming production capacity, and discussing their specific experimental goals with the provider before placing an order.